Staff View: Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods

Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods

The development of serotonin 5-HT3 receptor antagonists dramatically improved the treatment of chemotherapy-induced nausea and vomiting. Ondansetron, a serotonin 5-HT3 receptor antagonist in combination with dexamethasone is widely used to treat chemotherapy-induced nausea and vomiting. This treatme...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mahesh, R., Perumal, R.V., Vijayapandi, P.
Format:	Article
Published:	2005
Subjects:	R Medicine
Online Access:	http://eprints.um.edu.my/8133/
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my.um.eprints.8133
record_format	eprints
spelling	my.um.eprints.81332013-07-17T00:51:44Z http://eprints.um.edu.my/8133/ Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods Mahesh, R. Perumal, R.V. Vijayapandi, P. R Medicine The development of serotonin 5-HT3 receptor antagonists dramatically improved the treatment of chemotherapy-induced nausea and vomiting. Ondansetron, a serotonin 5-HT3 receptor antagonist in combination with dexamethasone is widely used to treat chemotherapy-induced nausea and vomiting. This treatment regimen is effective against acute nausea and vomiting, but fails to control delayed nausea and vomiting. Metoclopramide along with other antiemetics are used to treat delayed nausea and vomiting. The high doses of metoclopramide needed may produce extra pyramidal side effects. The recent developments of 5-HT3 and dopamine D-2 dual receptor antagonists have been found to exhibit a broad spectrum of activity against peripherally and centrally acting stimuli, but are not much effective against delayed emesis associated with chemotherapy. In various animal models, neurokinin NK1 receptor antagonists showed promising results against acute and delayed emesis, but the clinical trials revealed that triple therapy (NK1 receptor antagonist, 5-HT3 receptor antagonist and dexamethasone) is superior than standard therapy (5-HT3 receptor antagonist & dexamethasone) or NK1 receptor antagonist alone, in controlling acute as well as delayed nausea and vomiting. Ginger, which is used traditionally for controlling emesis induced by various stimuli, also showed good activity against chemotherapy-induced nausea and vomiting in animal models. Non-pharmacological methods such as acupressure and acustimulation are good adjunct methods in treating nausea and vomiting. Since many mediators are involved in emesis induced by chemotherapy, cocktail treatment is proven to be more efficacious than a single drug, but increases treatment costs. So there is a need of further research in this field to get economically useful methods for the treatment of acute and delayed chemotherapy-induced nausea and vomiting. 2005 Article PeerReviewed Mahesh, R. and Perumal, R.V. and Vijayapandi, P. (2005) Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods. Pharmazie, 60 (2). pp. 83-96. ISSN 0031-7144
institution	Universiti Malaya
building	UM Library
collection	Institutional Repository
continent	Asia
country	Malaysia
content_provider	Universiti Malaya
content_source	UM Research Repository
url_provider	http://eprints.um.edu.my/
topic	R Medicine
spellingShingle	R Medicine Mahesh, R. Perumal, R.V. Vijayapandi, P. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
description	The development of serotonin 5-HT3 receptor antagonists dramatically improved the treatment of chemotherapy-induced nausea and vomiting. Ondansetron, a serotonin 5-HT3 receptor antagonist in combination with dexamethasone is widely used to treat chemotherapy-induced nausea and vomiting. This treatment regimen is effective against acute nausea and vomiting, but fails to control delayed nausea and vomiting. Metoclopramide along with other antiemetics are used to treat delayed nausea and vomiting. The high doses of metoclopramide needed may produce extra pyramidal side effects. The recent developments of 5-HT3 and dopamine D-2 dual receptor antagonists have been found to exhibit a broad spectrum of activity against peripherally and centrally acting stimuli, but are not much effective against delayed emesis associated with chemotherapy. In various animal models, neurokinin NK1 receptor antagonists showed promising results against acute and delayed emesis, but the clinical trials revealed that triple therapy (NK1 receptor antagonist, 5-HT3 receptor antagonist and dexamethasone) is superior than standard therapy (5-HT3 receptor antagonist & dexamethasone) or NK1 receptor antagonist alone, in controlling acute as well as delayed nausea and vomiting. Ginger, which is used traditionally for controlling emesis induced by various stimuli, also showed good activity against chemotherapy-induced nausea and vomiting in animal models. Non-pharmacological methods such as acupressure and acustimulation are good adjunct methods in treating nausea and vomiting. Since many mediators are involved in emesis induced by chemotherapy, cocktail treatment is proven to be more efficacious than a single drug, but increases treatment costs. So there is a need of further research in this field to get economically useful methods for the treatment of acute and delayed chemotherapy-induced nausea and vomiting.
format	Article
author	Mahesh, R. Perumal, R.V. Vijayapandi, P.
author_facet	Mahesh, R. Perumal, R.V. Vijayapandi, P.
author_sort	Mahesh, R.
title	Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
title_short	Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
title_full	Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
title_fullStr	Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
title_full_unstemmed	Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
title_sort	cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods
publishDate	2005
url	http://eprints.um.edu.my/8133/
_version_	1643688225505542144
score	13.211869

Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods

Similar Items